Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Lithotripsy is a non-invasive treatment using ultrasonic shock waves to disintegrate kidney or ureteric stones to allow passage through the urinary tract system with less discomfort to the patient. Lithotripsy treats kidney stones by sending focused ultrasonic energy or shock waves directly to the stone first located with fluoroscopy or ultrasound. The shock waves break a large stone into smaller stones that will pass through the urinary system. Ultrasonic lithotripsy makes use of mechanical vibration to break stones into smaller fragments that may be aspirated with specialized probes. Lithotripsy has long proven to be an effective, less invasive method for breaking up stones in the kidney, bladder, or ureter.
The global lithotripsy devices market has gained outstanding growth due to increasing incidence of urolithiasis and growing adoption of minimally invasive techniques. Urolithiasis is a common urologic issue, and constitutes a significant burden on the healthcare system, worldwide. Affecting about 12% of the world population, it has been associated with an increased risk of end-stage renal failure, which has increased the demand for lithotripsy devices. Hence, the increasing prevalence of kidney stones is the major factor expected to drive the growth of the lithotripsy devices market, over the forecast period. The other driving factors includes the rise in number of extracorporeal shock wave lithotripsy procedures and technological advancements. However, adverse effects associated with lithotripsy and the availability of alternative treatments for stone removal are hindering the market growth.
The report analyses the global lithotripsy devices market based on type, application, end user and geography.
Based on type, the market is segmented into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices including laser lithotripsy devices, electrohydraulic lithotripsy devices, ultrasonic lithotripsy devices and mechanical lithotripsy devices. The extracorporeal shock wave lithotripsy (ESWL) was introduced as a non-invasive therapy solution for renal stones in 1980. Today it is the most common treatment method for urolithiasis. ESWL is characterised by a great success of the therapeutic outcome as well as low side effects.
Various applications of the global lithotripsy devices market include kidney stones, ureteral stones, pancreatic stones and bile duct stones. Intracorporeal lithotripsy can treat all compositions of kidney stones and has a high success rate for ureteral stones without any major complications.
End users of this market are hospitals, clinics, ambulatory surgical centers and other end users. Lithotripsy is usually done on an outpatient basis. High number of lithotripsy surgeries are performed in hospitals globally.
By geography, the global lithotripsy devices market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, and Rest of the world. North America accounted for the largest share in 2018, followed by Europe and Asia-Pacific. High prevalence of kidney stones and the large number of surgeries are fuelling the growth of lithotripsy devices in North America. Furthermore, Europe has been the second largest market for lithotripsy devices. This market is majorly boosted by the growing healthcare expenditure and launch of novel lithotripsy devices. In addition to this, the Asia-Pacific region is expected to grow at a lucrative growth rate during the forecast period. Development of new diagnostic centers & hospitals and expansion of healthcare companies are believed to be the market drivers in China, South Korea, and India.
Some of the major players operating in the global lithotripsy devices market include Siemens AG, Storz Medical AG, Boston Scientific, Olympus, Richard Wolf, Direxgroup, Novamedtek, Dornier Medtech, Medispec and Walz Elektronik.
The global lithotripsy devices market is segmented based on type, application, end user and geography. Based on type, the market is segmented into extracorporeal shock wave lithotripsy devices and intracorporeal lithotripsy devices including laser lithotripsy devices, electrohydraulic lithotripsy devices, ultrasonic lithotripsy devices and mechanical lithotripsy devices. The extracorporeal shock wave lithotripsy (ESWL) was introduced as a non-invasive therapy solution for renal stones in 1980.
Various applications of the global lithotripsy devices market include kidney stones, ureteral stones, pancreatic stones and bile duct stones. Intracorporeal lithotripsy can treat all compositions of kidney stones and has a high success rate for ureteral stones without any major complications.
End users of this market are hospitals, clinics, ambulatory surgical centers and other end users. Lithotripsy is usually done on an outpatient basis. High number of lithotripsy surgeries are performed in hospitals globally.
By geography, the global lithotripsy devices market is studied across the countries of key regions such as, North America, Europe, Asia Pacific, and Rest of the world. North America accounted for the largest share in 2018, followed by Europe and Asia-Pacific. High prevalence of kidney stones and the large number of surgeries are fuelling the growth of lithotripsy devices in North America.
Why to buy this report:
